Acebutolol
Back to searchMolecule Structure
Scientific Name
Acebutolol
Description of the Drug
Acebutolol is a selective β1-receptor antagonist used for the management of hypertension and ventricular premature beats in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01193
http://www.drugbank.ca/drugs/DB01193
Brand Name(s)
Not Available
Company Owner(s)
Mylan Pharmaceuticals Inc A Viatris Co, Ani Pharmaceuticals Inc, Promius Pharma Llc, Amneal Pharmaceutical
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3772 | |
PharmGKB | PA448011 | |
Human Metabolome Database | HMDB0015324 | |
DrugBank | DB01193 | |
PubChem: Thomson Pharma | 15075320 | |
PubChem | 1978 | |
Mcule | MCULE-6278379694 | |
LINCS | LSM-4384 | |
Nikkaji | J29.383K | |
BindingDB | 25755 | |
EPA CompTox Dashboard | DTXSID2048539 | |
DrugCentral | 40 | |
Brenda | 115127 | |
ChemicalBook | CB5393651 | |
Guide to Pharmacology | 7107 | |
rxnorm | ACEBUTOLOL | ACEBUTOLOL HYDROCHLORIDE |
KEGG Ligand | C06803 | |
ChEBI | 2379 |